Linda Woodhouse

Linda Woodhouse

(617) 636-3560
Arizona
Research/Areas of Interest:
My research focus is on reducing pain and improving physical function in adults with musculoskeletal, endocrine and autoimmune disorders. More recently, my focus has shifted towards developing, implementing and evaluating new models of appropriate care to build sustainable health care systems.

This work aligns under the following research themes:
(1) developing objective measures of pain, physical and functional capacity,
(2) evaluating the effects of muscle compounds (anabolic steroids, anti-myostatin antibodies) and exercise on physical function in aging individuals and those with musculoskeletal (e.g. osteoarthritis and sarcopenia) and endocrine disorders (e.g. growth hormone deficiency and excess),
(3) investigating the relationship between structure (cellular level), function (whole body level) and quality of life in individuals with musculoskeletal (low back pain, ACL deficiency, total hip and knee replacements), endocrine (growth hormone deficiency and acromegaly) and autoimmune (HIV) disorders,
(4) developing, implementing and evaluating new models of care that improve access, quality, patient satisfaction and cost of health care,
(5) education and knowledge translation to build sustainable health care systems.

Education

  • Master of Arts, Univ Of Western Ontario, CAN, 1990
  • Bachelor of Science (Physical Therapy), University of Toronto, Toronto, CAN, 1987
  • Doctor of Philosophy, University of Toronto, Toronto, Canada, 2005

Biography

Dr. Woodhouse is the Director of Research and Faculty Development for the Tufts DPT-Phoenix program. She has an international reputation with more than 30 years of experience as a researcher, educator and clinician. She has worked predominantly in the musculoskeletal area, developing and evaluating innovative models of integrated interprofessional care. Her research focus is on evaluating pain, physical and functional capacity in individuals with musculoskeletal and endocrine disorders, and evaluating the effects of muscle compounds (anabolic steroids, anti-myostatin antibodies) and exercise on sarcopenia. She has held or collaborated on $30 million in peer-reviewed grants, has published widely and has many invited presentations as an international speaker. Linda is an advocate for integrated data systems and the use of data to drive high quality, cost effective health care delivery. In Canada, she served as the inaugural Endowed Chair in Physical Therapy (2011-2016 and Scientific Director for Alberta Health Services' Provincial Bone & Joint Health Strategic Clinical Network (2012-2015). She has made significant contributions to physiotherapy and exercise science, including being elected to the Board of Directors of the Canadian Physiotherapy Association (CPA) in 2012 where she served as President of the CPA from 2015 to 2017. In Australia, she was head of the School of Physiotherapy and Exercise Science (2019-2021) at Curtin University.